Investing

Québec Communities Vote “No” to La Loutre Graphite Mine

September 6, 2025
Investing

Top 5 Canadian Mining Stocks This Week: Carlton Precious Gains 78 Percent

September 6, 2025
Investing

Lode Gold Closes $1.51 Million Upsized Private Placement

September 6, 2025
Investing

Editor’s Picks: Gold Sets New Price Record, Silver Hits 14 Year High

September 6, 2025
Politics

EXCLUSIVE: Franklin Graham praises VP Vance’s stand, critiques his ‘salty’ language in RFK Jr. defense

September 6, 2025
Politics

Loyal Ex-Biden aide says fateful debate against Trump was ‘overblown’ in closed-door House grilling

September 6, 2025
Home Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202
Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin
RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

You may also like

OPINION — Goldenomics 101: Follow the Money

July 19, 2025

Locksley Resources LimitedStrengthens Leadership to Accelerate Growth Strategy

September 2, 2025

What’s the Next US Copper Mine? 27 Copper...

April 24, 2025

Investment Protection Agreement with the Ecuador Government on...

May 28, 2025

Q1 2025 Management’s Discussion and Analysis

May 14, 2025

5 Best-performing Gold Stocks on the TSX in...

July 17, 2025

Binding Commitments Received for A$1.0 Million under Convertible...

April 28, 2025

HyProMag USA Receives “Make More in America” Domestic...

June 13, 2025

Adrian Day: Gold Price Drivers Stacking Up, Any...

July 15, 2025

Brunswick Exploration

June 19, 2025